Clinical Trial Update: Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of GSK1358820 in Japanese patients with urinary incontinence due to neurogenic detrusor overactivity has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Bladder Overactive
• Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Drugs mentioned

• GSK1358820

Snippet

Sponsor: GlaxoSmithKline | Conditions: Urinary Bladder, Overactive | Phase 3 | Status: COMPLETED | Results posted: 2019-07-10